ID   GSC23
AC   CVCL_DR59
SY   GSC-23
DR   BTO; BTO:0006538
DR   PRIDE; PXD000563
DR   Wikidata; Q54871750
RX   PubMed=24266786;
RX   PubMed=29887596;
CC   Group: Cancer stem cell line.
CC   Omics: Deep proteome analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 7
//
RX   PubMed=24266786; DOI=10.1021/pr400786s;
RA   Lichti C.F., Liu H.-L., Shavkunov A.S., Mostovenko E., Sulman E.P.,
RA   Ezhilarasan R., Wang Q.-H., Kroes R.A., Moskal J.C., Fenyo D.,
RA   Oksuz B.A., Conrad C.A., Lang F.F., Berven F.S., Vegvari A.,
RA   Rezeli M., Marko-Varga G., Hober S., Nilsson C.L.;
RT   "Integrated chromosome 19 transcriptomic and proteomic data sets
RT   derived from glioma cancer stem-cell lines.";
RL   J. Proteome Res. 13:191-199(2014).
//
RX   PubMed=29887596; DOI=10.1038/s41388-018-0301-5;
RA   Yu O.M., Benitez J.A., Plouffe S.W., Ryback D., Klein A., Smith J.,
RA   Greenbaum J., Delatte B., Rao A., Guan K.-L., Furnari F.B., Chaim O.M.,
RA   Miyamoto S., Brown J.H.;
RT   "YAP and MRTF-A, transcriptional co-activators of RhoA-mediated gene
RT   expression, are critical for glioblastoma tumorigenicity.";
RL   Oncogene 37:5492-5507(2018).
//